Instrumentation Laboratory buys Hemoliance:
This article was originally published in Clinica
Instrumentation Laboratory's parent company, Grupo CH-Werfen, is to buy Hemoliance, a joint venture between Medical Laboratory Automation and Ortho-Clinical Diagnostics, for around $130 million. Hemoliance, which manufactures and distributes haemostasis systems, has revenues of some $80 million. Instrumentation says the combined company will have an enhanced presence in the US market. Hemoliance is a leading supplier of synthetic and recombinant reagents and will bring Instrumentation a solid patent position with its instrument platform, the company says.